Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study

BACKGROUND: Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection. We evaluated the efficacy and safety of secnidazole vs placebo in women with trichomoniasis. METHODS: Women with trichomoniasis, confirmed by a positive T. vaginalis culture, were randomized to single-do...

Descripción completa

Detalles Bibliográficos
Autores principales: Muzny, Christina A, Schwebke, Jane R, Nyirjesy, Paul, Kaufman, Gregory, Mena, Leandro A, Lazenby, Gweneth B, Van Gerwen, Olivia T, Graves, Keonte J, Arbuckle, Janeen, Carter, Belvia A, McMahon, Connette P, Eder, Scott, Shaw, Jackie, Pandey, Brajesh, Chavoustie, Steven E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442793/
https://www.ncbi.nlm.nih.gov/pubmed/33768237
http://dx.doi.org/10.1093/cid/ciab242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442793/
https://www.ncbi.nlm.nih.gov/pubmed/33768237
http://dx.doi.org/10.1093/cid/ciab242

Ejemplares similares